Jamsranjav, Enkhtsetseg

Now showing 1 - 2 of 2

Some of the metrics are blocked by your
consent settings
Outcome of Uterine Artery Embolization in the Treatment of Uterine Leiomyomas in Mongolia
(Mongolian National University of Medical Sciences, 2018-03-25)
Rentsenkhuu, Uranchimeg
;
Rentsenkhuu, Ganbaatar
;
Lkhagva, Bayarmaa
;
Tsevegmid, Erdembileg
;
Jamsranjav, Enkhtsetseg
Objective: To evaluate and determine treatment efficacy of uterine artery embolization versus uterine myomectomy in treating uterine leiomyomas. Methods: In 2010-2013, 94 women between the ages of 23-50 years were recruited in the study. They were divided into 2 treatment groups: uterine artery embolization and myomectomy (control) group and were followed up for two consecutive years. Results: After uterine artery embolization, the volume of leiomyomas decreased 56%-91% (p<0.05). Menorrhagia in the uterine artery embolization versus myomectomy group was 95.2% and 92.8% (p>0.05), anemia 87.5% and 85.7% (p>0.05), pain subsided 72.2% versus 86.8% and "bulk" symptoms 87.5% versus 100% respectively (p>0.05). Overall health-related quality of life score +27.6 versus +17.1 and SS score -34.0 versus -32.8, patient satisfaction 89.4% versus 72.3% (p=0.001). Re-growth after uterine artery embolization 2.1% versus myomectomy 23.4% (p=0.0001), Post-treatment conception 25.5% versus 31.9% and cesarean delivery rate 88.9% versus 90% respectively (p>0.05). Duration of the procedure 38.9±4.8 minutes versus 54.0±26.3 minutes (p=0.0001), length of hospital stay 2.4±0.9 days versus 6.9±2.3 days (p=0.0001), days to recovery 10.6±3.0 versus 26.2±17.9 (p=0.0001). Conclusion: Uterine artery embolization treatment effectively decreases the size of leiomyomas (p=0.015), it particularly improves menorrhagia. The quality of life and patient satisfaction scores after uterine artery embolization are better (p=0.001). There was no statistically significant difference with regard to conception rate or the need for cesarean delivery (p>0.05).
Some of the metrics are blocked by your
consent settings
Effect of Mycoplasma hominis and cytomegalovirus infection on pregnancy outcome: A prospective study of 200 Mongolian women and their newborns
(2017)
Otgonjargala, Byambaa
;
Becker, Kathrin
;
Batbaatar, Gunchin
;
Tsogtsaikhan, Sandag
;
Enkhtsetseg, Jamsranjav
In Mongolia, diagnostic tests for the detection of the sexually transmitted mycoplasmas, ureaplasmas, Herpes simplex virus (HSV), and cytomegalovirus (CMV) are currently not routinely used in clinical settings and the frequency of these STIs are enigmatic. The prevalence of these STI pathogens were prospectively evaluated among 200 Mongolian pregnant women and their newborns and correlated with pregnancy outcome. TaqMan PCRs were used to detect bacterial and viral STI pathogens in pre-birth vaginal swabs of the pregnant women and in oral swabs of their newborns. A standardized questionnaire concerning former and present pregnancies was developed and linear regression analysis was used to correlate pathogen detection with pregnancy outcome. Ureaplasmas were the most prevalent of the tested pathogens (positive in 90.5% positive women and 47.5% newborns), followed by mycoplasmas (32.5% and 7.5%), chlamydia (14.5% and 7.5%), trichomonas (8.5% and 4.0%) and gonococcus (0.5% and 0%). CMV was found in 46.5% of the pregnant women and in 10.5% of their newborns, whereas HSV-2 was detected in only two mothers. Multiple regression analyses indicate that colonization of the mothers with U. urealyticum, M. hominis, T. vaginalis or CMV is associated with transmission to newborns and that transmission of M. hominis or CMV from Mongolian pregnant women to offspring is associated with reduced neonatal length and gestational age. Thus, diagnostic tests for their detection should be implemented in the clinical settings in Mongolia.
Scopus© Citations 12

Jamsranjav, Enkhtsetseg

Filters

Settings

Sort By

Results per page